In the United States, 25 million people have asthma and every year more people are affected by it. Dr. Mitchell Grayson of Nationwide Children’s Hospital developed a novel use of INV-102 for the treatment and prevention of asthma. The therapeutic would alleviate symptoms of asthma or a post-viral infection like shortness of breath, chest tightness and pain, coughing and wheezing.